Innocan Pharma Corp (CSE: INNO )

0.2300 +0.0300 (+15.00%)
Streaming Delayed Price Updated: 9:47 AM EST, Nov 11, 2024 Add to My Watchlist

Other Filings

Form 8-K/A
Source: SEC/Edgar
December 05, 2013
Form 8-K
Source: SEC/Edgar
October 14, 2013
Form 8-K
Source: SEC/Edgar
October 03, 2013
Form 8-K
Source: SEC/Edgar
August 27, 2013
Form SC 13D/A
Source: SEC/Edgar
July 23, 2013
Form 8-K
Source: SEC/Edgar
July 18, 2013
Form 8-K
Source: SEC/Edgar
July 14, 2013
Form 8-K
Source: SEC/Edgar
July 02, 2013
Form 8-K
Source: SEC/Edgar
July 02, 2013
Form 8-K
Source: SEC/Edgar
April 14, 2013
Form 8-K
Source: SEC/Edgar
April 11, 2013
Form DEF 14A
Source: SEC/Edgar
March 10, 2013
Form 8-K
Source: SEC/Edgar
February 20, 2013
Form 8-K
Source: SEC/Edgar
February 18, 2013
Form 8-K
Source: SEC/Edgar
February 05, 2013
Form 8-K
Source: SEC/Edgar
January 21, 2013
Form 8-K
Source: SEC/Edgar
January 14, 2013
Form 8-K
Source: SEC/Edgar
December 20, 2012
Form 8-K
Source: SEC/Edgar
December 10, 2012
Form 8-K
Source: SEC/Edgar
November 19, 2012
Form 8-K
Source: SEC/Edgar
October 14, 2012
Form DEF 14A
Source: SEC/Edgar
October 08, 2012
Form 8-K
Source: SEC/Edgar
July 15, 2012
Form 8-K
Source: SEC/Edgar
April 11, 2012
Form 8-K
Source: SEC/Edgar
April 02, 2012
Form 8-K
Source: SEC/Edgar
March 22, 2012
Form 8-K
Source: SEC/Edgar
March 04, 2012
Form 8-K
Source: SEC/Edgar
February 27, 2012
Form S-8
Source: SEC/Edgar
February 27, 2012
Form 8-K
Source: SEC/Edgar
February 16, 2012
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.